Rapid response to cyclosporin A and favorable renal outcome in nongenetic versus genetic steroid-resistant nephrotic syndrome

Background and objectives Treatment of congenital nephrotic syndrome (CNS) and steroid-resistant nephrotic syndrome (SRNS) is demanding, and renal prognosis is poor. Numerous causative gene mutations have been identified in SRNS that affect the renal podocyte. In the era of high-throughput sequencin...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Büscher, Anja K. (VerfasserIn) , Beck, Bodo B. (VerfasserIn) , Melk, Anette (VerfasserIn) , Hoefele, Julia (VerfasserIn) , Kranz, Birgitta (VerfasserIn) , Bamborschke, Daniel (VerfasserIn) , Baig, Sabrina (VerfasserIn) , Lange-Sperandio, Bärbel (VerfasserIn) , Jungraithmayr, Theresa (VerfasserIn) , Weber, Lutz T. (VerfasserIn) , Kemper, Markus J. (VerfasserIn) , Tönshoff, Burkhard (VerfasserIn) , Hoyer, Peter F. (VerfasserIn) , Konrad, Martin (VerfasserIn) , Weber, Stefanie (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: r2015
In: Clinical journal of the American Society of Nephrology
Year: 2016, Jahrgang: 11, Heft: 2, Pages: 245-253
ISSN:1555-905X
DOI:10.2215/CJN.07370715
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.2215/CJN.07370715
Verlag, lizenzpflichtig, Volltext: https://cjasn.asnjournals.org/content/11/2/245
Volltext
Verfasserangaben:Anja K. Büscher, Bodo B. Beck, Anette Melk, Julia Hoefele, Birgitta Kranz, Daniel Bamborschke, Sabrina Baig, Bärbel Lange-Sperandio, Theresa Jungraithmayr, Lutz T. Weber, Markus J. Kemper, Burkhard Tönshoff, Peter F. Hoyer, Martin Konrad, and Stefanie Weber for the German Pediatric Nephrology Association (GPN)

MARC

LEADER 00000caa a2200000 c 4500
001 1696124042
003 DE-627
005 20230426182213.0
007 cr uuu---uuuuu
008 200424s2016 xx |||||o 00| ||eng c
024 7 |a 10.2215/CJN.07370715  |2 doi 
035 |a (DE-627)1696124042 
035 |a (DE-599)KXP1696124042 
035 |a (OCoLC)1341316892 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Büscher, Anja K.  |e VerfasserIn  |0 (DE-588)1208220543  |0 (DE-627)1694431029  |4 aut 
245 1 0 |a Rapid response to cyclosporin A and favorable renal outcome in nongenetic versus genetic steroid-resistant nephrotic syndrome  |c Anja K. Büscher, Bodo B. Beck, Anette Melk, Julia Hoefele, Birgitta Kranz, Daniel Bamborschke, Sabrina Baig, Bärbel Lange-Sperandio, Theresa Jungraithmayr, Lutz T. Weber, Markus J. Kemper, Burkhard Tönshoff, Peter F. Hoyer, Martin Konrad, and Stefanie Weber for the German Pediatric Nephrology Association (GPN) 
264 1 |c r2015 
300 |a 9 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Accepted October 30, 2015 
500 |a Gesehen am 24.04.2020 
520 |a Background and objectives Treatment of congenital nephrotic syndrome (CNS) and steroid-resistant nephrotic syndrome (SRNS) is demanding, and renal prognosis is poor. Numerous causative gene mutations have been identified in SRNS that affect the renal podocyte. In the era of high-throughput sequencing techniques, patients with nongenetic SRNS frequently escape the scientific interest. We here present the long-term data of the German CNS/SRNS Follow-Up Study, focusing on the response to cyclosporin A (CsA) in patients with nongenetic versus genetic disease. - Design, setting, participants, & measurements Cross-sectional and longitudinal clinical data were collected from 231 patients with CNS/SRNS treated at eight university pediatric nephrology units with a median observation time of 113 months (interquartile range, 50-178). Genotyping was performed systematically in all patients. - Results The overall mutation detection rate was high at 57% (97% in CNS and 41% in SRNS); 85% of all mutations were identified by the analysis of three single genes only (NPHS1, NPHS2, and WT1), accounting for 92% of all mutations in patients with CNS and 79% of all mutations in patients with SRNS. Remission of the disease in nongenetic SRNS was observed in 78% of patients after a median treatment period of 2.5 months; 82% of nongenetic patients responded within 6 months of therapy, and 98% of patients with nongenetic SRNS and CsA-induced complete remission (normalbuminemia and no proteinuria) maintained a normal renal function. Genetic SRNS, on the contrary, is associated with a high rate of ESRD in 66% of patients. Only 3% of patients with genetic SRNS experienced a complete remission and 16% of patients with genetic SRNS experienced a partial remission after CsA therapy. - Conclusions The efficacy of CsA is high in nonhereditary SRNS, with an excellent prognosis of renal function in the large majority of patients. CsA should be given for a minimum period of 6 months in these patients with nongenetic SRNS. In genetic SRNS, response to CsA was low and restricted to exceptional patients. 
650 4 |a cyclosporine A 
650 4 |a FSGS 
650 4 |a humans 
650 4 |a kidney failure, chronic 
650 4 |a mutation 
650 4 |a NPHS1 
650 4 |a NPHS2 
650 4 |a steroid resistant nephrotic syndrome 
650 4 |a WT1 
700 1 |a Beck, Bodo B.  |e VerfasserIn  |4 aut 
700 1 |a Melk, Anette  |e VerfasserIn  |4 aut 
700 1 |a Hoefele, Julia  |e VerfasserIn  |4 aut 
700 1 |a Kranz, Birgitta  |e VerfasserIn  |4 aut 
700 1 |a Bamborschke, Daniel  |e VerfasserIn  |4 aut 
700 1 |a Baig, Sabrina  |e VerfasserIn  |4 aut 
700 1 |a Lange-Sperandio, Bärbel  |e VerfasserIn  |4 aut 
700 1 |a Jungraithmayr, Theresa  |e VerfasserIn  |4 aut 
700 1 |a Weber, Lutz T.  |e VerfasserIn  |4 aut 
700 1 |a Kemper, Markus J.  |e VerfasserIn  |4 aut 
700 1 |a Tönshoff, Burkhard  |e VerfasserIn  |0 (DE-588)1032445823  |0 (DE-627)738463493  |0 (DE-576)173494196  |4 aut 
700 1 |a Hoyer, Peter F.  |e VerfasserIn  |4 aut 
700 1 |a Konrad, Martin  |e VerfasserIn  |4 aut 
700 1 |a Weber, Stefanie  |e VerfasserIn  |0 (DE-588)1212141199  |0 (DE-627)1700759620  |4 aut 
773 0 8 |i Enthalten in  |a American Society of Nephrology  |t Clinical journal of the American Society of Nephrology  |d Washington, DC : American Society of Nephrology, 2006  |g 11(2016), 2, Seite 245-253  |h Online-Ressource  |w (DE-627)50595091X  |w (DE-600)2216582-4  |w (DE-576)30683281X  |x 1555-905X  |7 nnas 
773 1 8 |g volume:11  |g year:2016  |g number:2  |g pages:245-253  |g extent:9  |a Rapid response to cyclosporin A and favorable renal outcome in nongenetic versus genetic steroid-resistant nephrotic syndrome 
856 4 0 |u https://doi.org/10.2215/CJN.07370715  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://cjasn.asnjournals.org/content/11/2/245  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20200424 
993 |a Article 
994 |a 2016 
998 |g 1032445823  |a Tönshoff, Burkhard  |m 1032445823:Tönshoff, Burkhard  |d 910000  |d 910500  |e 910000PT1032445823  |e 910500PT1032445823  |k 0/910000/  |k 1/910000/910500/  |p 12 
999 |a KXP-PPN1696124042  |e 3633473947 
BIB |a Y 
SER |a journal 
JSO |a {"person":[{"roleDisplay":"VerfasserIn","display":"Büscher, Anja K.","role":"aut","family":"Büscher","given":"Anja K."},{"given":"Bodo B.","family":"Beck","role":"aut","roleDisplay":"VerfasserIn","display":"Beck, Bodo B."},{"family":"Melk","given":"Anette","roleDisplay":"VerfasserIn","display":"Melk, Anette","role":"aut"},{"given":"Julia","family":"Hoefele","role":"aut","display":"Hoefele, Julia","roleDisplay":"VerfasserIn"},{"display":"Kranz, Birgitta","roleDisplay":"VerfasserIn","role":"aut","family":"Kranz","given":"Birgitta"},{"roleDisplay":"VerfasserIn","display":"Bamborschke, Daniel","role":"aut","family":"Bamborschke","given":"Daniel"},{"roleDisplay":"VerfasserIn","display":"Baig, Sabrina","role":"aut","family":"Baig","given":"Sabrina"},{"roleDisplay":"VerfasserIn","display":"Lange-Sperandio, Bärbel","role":"aut","family":"Lange-Sperandio","given":"Bärbel"},{"given":"Theresa","family":"Jungraithmayr","role":"aut","roleDisplay":"VerfasserIn","display":"Jungraithmayr, Theresa"},{"family":"Weber","given":"Lutz T.","roleDisplay":"VerfasserIn","display":"Weber, Lutz T.","role":"aut"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Kemper, Markus J.","given":"Markus J.","family":"Kemper"},{"family":"Tönshoff","given":"Burkhard","display":"Tönshoff, Burkhard","roleDisplay":"VerfasserIn","role":"aut"},{"given":"Peter F.","family":"Hoyer","role":"aut","display":"Hoyer, Peter F.","roleDisplay":"VerfasserIn"},{"given":"Martin","family":"Konrad","role":"aut","display":"Konrad, Martin","roleDisplay":"VerfasserIn"},{"given":"Stefanie","family":"Weber","role":"aut","display":"Weber, Stefanie","roleDisplay":"VerfasserIn"}],"title":[{"title":"Rapid response to cyclosporin A and favorable renal outcome in nongenetic versus genetic steroid-resistant nephrotic syndrome","title_sort":"Rapid response to cyclosporin A and favorable renal outcome in nongenetic versus genetic steroid-resistant nephrotic syndrome"}],"note":["Accepted October 30, 2015","Gesehen am 24.04.2020"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"recId":"1696124042","name":{"displayForm":["Anja K. Büscher, Bodo B. Beck, Anette Melk, Julia Hoefele, Birgitta Kranz, Daniel Bamborschke, Sabrina Baig, Bärbel Lange-Sperandio, Theresa Jungraithmayr, Lutz T. Weber, Markus J. Kemper, Burkhard Tönshoff, Peter F. Hoyer, Martin Konrad, and Stefanie Weber for the German Pediatric Nephrology Association (GPN)"]},"origin":[{"dateIssuedKey":"2016","dateIssuedDisp":"r2015"}],"id":{"eki":["1696124042"],"doi":["10.2215/CJN.07370715"]},"physDesc":[{"extent":"9 S."}],"relHost":[{"id":{"issn":["1555-905X"],"eki":["50595091X"],"zdb":["2216582-4"]},"origin":[{"dateIssuedKey":"2006","publisher":"American Society of Nephrology","dateIssuedDisp":"2006-","publisherPlace":"Washington, DC"}],"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title":"Clinical journal of the American Society of Nephrology","subtitle":"CJASN","title_sort":"Clinical journal of the American Society of Nephrology"}],"part":{"pages":"245-253","issue":"2","year":"2016","extent":"9","volume":"11","text":"11(2016), 2, Seite 245-253"},"titleAlt":[{"title":"CJASN"}],"pubHistory":["1.2006 -"],"recId":"50595091X","corporate":[{"display":"American Society of Nephrology","roleDisplay":"VerfasserIn","role":"aut"}],"language":["eng"],"disp":"American Society of NephrologyClinical journal of the American Society of Nephrology","note":["Gesehen am 04.08.2025"],"type":{"bibl":"periodical","media":"Online-Ressource"}}]} 
SRT |a BUESCHERANRAPIDRESPO2015